tndan derivatives of the formula:
wherein R1 is substituted or unsubstituted phenyl, naphthyl or sulfur-containing heterocyclic group, and R2 is hydroxymethyl or a group of the formula:
wherein R3 is hydrogen atom or lower alkyl and R4 is cycloalkyl, lower alkoxycarbonyl-phenyl, carboxy-phenyl, nitrogen-containing heterocyclic group, lower alkyl, or lower alkyl having a substituent selected from lower alkoxycarbonyl, carboxy, lower alkoxycarbonyl-phenyl, carboxy-phenyl, lower alkoxycarbonyl-cycloalkyl and carboxy-cycloalkyl, or a pharmaceutically acceptable salt thereof, which are useful as a platelet aggregation-inhibiting agent and as an agent for the treatment, amelioration and/or prophylaxis of a variety of thrombosis or embolism, coronary and cerebral vascular smooth muscle vellication, asthma, and the like, processes for the preparation thereof, and pharmaceutical composition containing said compound as an active ingredient.
式中 R1 为取代或未取代的苯基、
萘基或含
硫杂环基团,R2 为羟甲基或式中
其中 R1 是取代或未取代的苯基、
萘基或含
硫杂环基团,R2 是羟甲基或式中的一个基团:
其中 R3 是氢原子或低级烷基,R4 是环烷基、低级烷氧基羰基苯基、羧基苯基、含氮杂环基团、低级烷基或具有选自低级烷氧基羰基、羧基、低级烷氧基羰基苯基、羧基苯基、低级烷氧基羰基环烷基和羧基环烷基的取代基的低级烷基,或其药学上可接受的盐、可用作血小板聚集
抑制剂和治疗、改善和/或预防各种血栓形成或栓塞、冠状动脉和脑血管平滑肌肿胀、哮喘等的药物、其制备工艺以及含有上述化合物作为活性成分的药物组合物。